Philip Morris International (PM) is back in focus after publicly urging the European Union to treat tobacco like any other legal business ahead of upcoming reviews of tobacco taxation and product rules.

Philip Morris International’s recent push on EU regulation comes after a mixed run in the share price, with a 30 day share price return down 5.4% but a 90 day share price return up 10%. Longer term total shareholder returns over 3 and 5 years, at 111.32% and 127.87% respectively, point to a stock where momentum has generally built over time despite periodic volatility around regulatory headlines and leadership changes.

If this regulatory story has you rethinking where you look for ideas beyond tobacco, it could be a good moment to widen your search and check out 20 top founder-led companies

With Philip Morris International stock up 11.5% year to date but down 5.4% over the past month, and trading at a small discount to analyst price targets yet a premium to some intrinsic estimates, is there still an opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 7.4% Undervalued

Based on the most followed narrative, Philip Morris International’s fair value of $193.14 sits above the last close of $178.78, setting up a valuation story closely tied to smoke free growth and profitability assumptions.

The accelerating global adoption of smoke-free alternatives, driven by increasing health awareness and regulatory moves away from combustibles, is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.

Want to see what sits behind that smoke free thesis? The narrative leans on a specific revenue glide path, higher margins, and a future earnings multiple that assumes those trends stay intact.

Result: Fair Value of $193.14 (UNDERVALUED)

However, the Philip Morris International narrative could be upended if EU tax or product rules tighten more than expected, or if smoke free product momentum slows materially.

Another View on Philip Morris International’s Valuation

The analyst narrative paints Philip Morris International as about 7.4% below its $193.14 fair value, but the current P/E of 25.2x tells a more cautious story. That multiple sits above the US peer average at 23x and far above the global tobacco average at 12x, even though it matches the fair ratio of 25.2x modeled by Simply Wall St. For you, that mix of premium pricing and fair ratio alignment raises a simple question: is this a fully valued quality story or a set up for disappointment if expectations slip?

For a closer look at how these P/E gaps might affect valuation risk and opportunity, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and concern around Philip Morris International leaves you undecided, review the data while it is recent and evaluate the numbers yourself using the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Philip Morris International?

If you stop with Philip Morris International, you might miss other opportunities that fit your style, so put a few minutes into scanning fresh ideas with the Simply Wall St screener.

• Target resilient cash generators and uncover opportunities with strong fundamentals using the solid balance sheet and fundamentals stocks screener (48 results)
• Hunt for potential mispricings by scanning companies that look attractively priced on quality and value through the 44 high quality undervalued stocks
• Focus on income potential and stability by reviewing companies yielding 5% or more using the 7 dividend fortresses

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.